Compare TXMD & VBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXMD | VBIX |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9M | 21.2M |
| IPO Year | N/A | N/A |
| Metric | TXMD | VBIX |
|---|---|---|
| Price | $2.49 | $1.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 121.4K | 33.7K |
| Earning Date | 03-26-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $2,796,000.00 | ★ $11,056,000.00 |
| Revenue This Year | $427.09 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $91.22 | ★ N/A |
| Revenue Growth | ★ 75.19 | N/A |
| 52 Week Low | $0.72 | $0.96 |
| 52 Week High | $2.95 | $9.80 |
| Indicator | TXMD | VBIX |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 47.94 |
| Support Level | $2.12 | $1.75 |
| Resistance Level | $2.54 | $1.85 |
| Average True Range (ATR) | 0.27 | 0.15 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 36.78 | 19.33 |
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.